Radium-223 has demonstrated efficacy in improving overall survival (OS) and in delaying symptomatic skeletal-related events (SREs). Bone Health Agents (BHA), i.e. RANK ligand inhibitor (Denosumab) and bisphosphonate such as zoledronic acid, are indicated to prevent SREs without a clear survival benefit. SREs on patient health have a high impact and it is, therefore, important to consider the role of new therapies with BHA to better understand the involvement of combination therapy. The primary aim of this multicentric study is to assess OS in mCRPC patients treated with Radium-223 in combination with BHA.
Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study / Frantellizzi, Viviana; Monari, Fabio; Mascia, Manlio; Costa, Renato; Rubini, Giuseppe; Spanu, Angela; Farcomeni, Alessio; Lodi Rizzini, Elisa; Cindolo, Luca; Licari, Maria; Lavelli, Valentina; Nuvoli, Susanna; Ricci, Maria; Dionisi, Valeria; Nappi, Anna Giulia; De Vincentis, Giuseppe. - In: INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. - ISSN 0955-3002. - (2020), pp. 1-6. [10.1080/09553002.2020.1838655]
Titolo: | Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study | |
Autori: | DE VINCENTIS, Giuseppe (Ultimo) | |
Data di pubblicazione: | 2020 | |
Rivista: | ||
Citazione: | Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study / Frantellizzi, Viviana; Monari, Fabio; Mascia, Manlio; Costa, Renato; Rubini, Giuseppe; Spanu, Angela; Farcomeni, Alessio; Lodi Rizzini, Elisa; Cindolo, Luca; Licari, Maria; Lavelli, Valentina; Nuvoli, Susanna; Ricci, Maria; Dionisi, Valeria; Nappi, Anna Giulia; De Vincentis, Giuseppe. - In: INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. - ISSN 0955-3002. - (2020), pp. 1-6. [10.1080/09553002.2020.1838655] | |
Handle: | http://hdl.handle.net/11573/1455290 | |
Appartiene alla tipologia: | 01a Articolo in rivista |
File allegati a questo prodotto
File | Note | Tipologia | Licenza | |
---|---|---|---|---|
Frantellizzi_Overall survival_2020.pdf | Versione editoriale (versione pubblicata con il layout dell'editore) | Tutti i diritti riservati (All rights reserved) | Administrator Richiedi una copia |